Archive for October, 2019
Recent Rosacea Blog Posts
Having been sold just 1 year ago to Aclaris, the topical redness treatment for rosacea, Rhofade has again changed hands – this time to EPI Health. The value of the transaction is around $55m. Rhofade was previously owned by Allergan. What is Rhofade? Rhofade is Oxymetazoline HCL 1% Cream for the Redness of Rosacea. Officially […]
